Results 201 to 210 of about 2,456,516 (297)
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon +11 more
wiley +1 more source
Efficiency hierarchy and optimization of waste incineration in China to balance disposal and energy supply. [PDF]
Cui J +10 more
europepmc +1 more source
Keyed Intrusion Detection System for Key-Recovery Attacks
openaire +1 more source
ABSTRACT Objective High‐resolution MRI enables detailed assessment of intracranial vessel wall pathology in moyamoya vasculopathy. We aimed to classify adult moyamoya vasculopathy etiologies using high‐resolution MRI and to examine subtype‐specific associations between high‐resolution MRI features and ischemic infarction.
Guangsong Han +8 more
wiley +1 more source
Independent predictors of long-term pulmonary function recovery in patients with acute respiratory distress syndrome: a meta-analysis. [PDF]
Lu J, Fan J, Zeng W, Zhang Z, Zhang D.
europepmc +1 more source
Survey on Keyed IDS and Key Recovery Attacks
openaire +1 more source
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti +19 more
wiley +1 more source
Disparities in ACL Injury and Management: The Impact of Sex, Race, and Social Determinants of Health. [PDF]
Walker PB +5 more
europepmc +1 more source
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner +14 more
wiley +1 more source

